| Name | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate |
|---|---|
| Synonyms |
Capecitabine Intermediate-3
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate carbonyl]cytidine 2',3'-diacetate Capecitabine interMediate Pentyl [1-(2,3-Di-O-acetyl-5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]ca Pentyl [1-(2,3-Di-O-acetyl-5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]cbamate 5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate Capecitabine Impurity 7(Capecitabine Impurity G) ICytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-Di-O-acetylcapecitabine Capecitabine Impurity 7 5'- deoxy -5- fluoro -N-[ (pentoxy) carbonyl] cytidine 2',3'- diacetate Capecitabine 2',3'-diacetate [1-(2,3-Di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyriMidinyl]cbaMic Acid Pentyl Ester 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycboxyl)cytidine dihydro-2-oxo-4-pyrimidinyl]-, pentylester 5'-Deoxy-5-fluoro-N-[(pentyloxy) 5'-deoxy-5-fluore-N-[(pentyloxy) carbonyl] cytidine 2',3'-diacetate Capecitabine Impurity 2 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diac 5''-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2'',3''-diacetate Capecitabine Intermediate 1 T6NVNJ DMVO5 EF A- BT5OTJ COV1 DOV1 E1 &&Ribo-β-D Form 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentyloxycbonyl)cytidine 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate 5'-deoxi-5-fluoro-N-(pentyloxy)carbonyl cytidine-2',3'- diacetate Capecitabine Impurity G uoro-N-[(pentyL [(2R,3R,4R,5R)-4-acetyloxy-5-[5-fluoro-2-oxo-4-(pentoxycarbonylamino)pyrimidin-1-yl]-2-methyloxolan-3-yl] acetate 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentoxycbonxyl)cytidine Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 2', 3'-Di-O-acetyl-5'-Deoxy-5-Fuluro-N4-(Pentoxycbonxyl)-Cytidine 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-(pentoxycboxyl)cytidine 5'Deoxy5fluoroN[(pentyloxy)carbonyl]cytidine 2',3'diacetate,5' Deoxy 5 fluoro N [(pentyloxy)carbonyl]cytidine 2',3' diacetate ]cytidine 2',3'-diacetate Capecitabine impurity J 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 5'-Deoxy-5-fL 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate 5' Capecitabine-7 Cytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate Capecitabin iMpurity J (2R,3R,4R,5R)-2-(5-fluoro-2-oxo-4-(((pentyloxy)carbonyl)amino)pyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate 2', 3'-Di-O-acetyl-5'-Deoxy-5-F-N4-(Pentoxycbonxyl)-Cytidine |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Melting Point | 111 °C |
| Molecular Formula | C19H26FN3O8 |
| Molecular Weight | 443.423 |
| Exact Mass | 443.170380 |
| PSA | 135.05000 |
| LogP | 2.14 |
| Index of Refraction | 1.567 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934999090 |
|
~28%
162204-20-8 |
| Literature: Coll Farma S.L. Patent: EP2241556 A1, 2010 ; Location in patent: Page/Page column 9 ; |
|
~%
162204-20-8 |
| Literature: Shimma, Nobuo; Umeda, Isao; Arasaki, Motohiro; Murasaki, Chikako; Masubuchi, Kazunao; Kohchi, Yasunori; Miwa, Masanori; Ura, Masako; Sawada, Noriaki; Tahara, Hitoshi; Kuruma, Isamu; Horii, Ikuo; Ishitsuka, Hideo Bioorganic and Medicinal Chemistry, 2000 , vol. 8, # 7 p. 1697 - 1706 |
|
~%
162204-20-8 |
| Literature: Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| Literature: Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| Literature: Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
162204-20-8 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
| Precursor 6 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |